bsm-52120R [Primary Antibody]
IRF7 (2A1) Monoclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: IRF7

Clonality: Monoclonal

Isotype: IgG

Entrez Gene: 3665

Swiss Prot: Q92985

Source: Recombinant human IRF7 protein, around 200-300aa.

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.

Background:

The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is essential for mediating responses to IL12 in lymphocytes, and regulating the differentiation of T helper cells. Mutations in this gene may be associated with systemic lupus erythematosus and rheumatoid arthritis. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Aug 2011].

Size: 100ul

Concentration: 1ug/ul

Cross Reactive Species: Human

For research use only. Not intended for diagnostic or therapeutic use.

VALIDATION IMAGES

Lane 1: Jurkat; Lane 2: Raji lysates probed with IRF7 (2A1) Monoclonal Antibody (bsm-52120R) at 1:1000 overnight at 4˚C. Followed by a conjugated secondary antibody.


293 cells were stained with IRF7 (2A1) Monoclonal Antibody (bsm-52120R) at [1:200] incubated overnight at 4C, followed by secondary antibody incubation, DAPI staining of the nuclei and detection.


Lane 1: Human Jurkat cell lysates; Lane 2: Human Raji cell lysates; Lane 3: Human HepG2 cell lysates; Lane 4: Human 293T cell lysates; Lane 5: Human MOLT-4 cell lysates; Lane 6: Human HUVEC cell lysates probed with IRF7 (2A1) Monoclonal Antibody, Unconjugated (bsm-52120R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.